Source: US News & World Report
“Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might still win approval after Health Secretary Robert F. Kennedy Jr cast doubt on its efficacy. The Novavax vaccine is the only COVID-19 booster in the United States that does not use messenger RNA technology — which some states have begun to ban — and the only option for many people who cannot or will not take an mRNA vaccine. … Novavax has been available since 2022 through a pandemic-era Emergency Use Authorization. A decision on full approval – which rival mRNA shots from Moderna and Pfizer and its partner BioNTech already have – was due from the Food and Drug Administration by April 1, but had been delayed by the FDA without explanation.” (04/24/25)